Paradigm Biopharmaceuticals Ltd (ASX: PAR) — Healthcare · Share Price, Chart & Market Data
About: Paradigm Biopharmaceuticals Limited engages in the research and development of therapeutic products for human use in Australia. Its lead candidate is Zilosul, an injectable pentosan polysulfate sodium drugs for the treatment of osteoarthritis, mucopolysaccharidosis, ross river virus, chikungunya virus, chronic heart failure, allergic respiratory, and acute respiratory distress syndrome diseases. The company was incorporated in 2014 and is headquartered in Melbourne, Australia.
Sector: Healthcare
Industry: Biotechnology
Latest price: A$0.19 (-15.56%)
PARParadigm Biopharmaceuticals Ltd
Loading watchlist status…
Trade PAR now
Paradigm Biopharmaceuticals Ltd share price
PAR price activity
Last Price
Change (24hr)
AUD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
27 Apr, 10:31 am GMT+0
PAR price performance
-19.149%
5D
-25.49%
1M
-44.118%
YTD
-38.71%
1Y
PAR price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
ASX rank
N/A
Sector Rank
N/A
Delayed
27 Apr, 10:31 am GMT+0
PAR details
PAR Market Signals